Literature DB >> 15800155

Further evidence for altered cerebellar neuronal integrity in schizophrenia.

Gabriele Ende1, Petra Hubrich, Sigrid Walter, Wolfgang Weber-Fahr, Nina Kämmerer, Dieter F Braus, Fritz A Henn.   

Abstract

OBJECTIVE: The authors' goal was to investigate the distribution of metabolites and voxel composition in the pons and three cerebellar subregions and compare metabolite integral values and differences in voxel composition between patients with schizophrenia and healthy subjects.
METHOD: Proton magnetic resonance spectroscopic imaging was used to study the cerebellum and pons of 14 patients with schizophrenia and 14 healthy comparison subjects.
RESULTS: The voxel composition was not significantly different between the groups, but the patients with schizophrenia had significantly lower N-acetylaspartate levels in the cerebellar cortex and vermis.
CONCLUSIONS: The lower integral value of N-acetylaspartate in the cerebellar cortex and the vermis of patients with schizophrenia supports the theory of a dysfunctional corticocerebellar-thalamic-cortical circuit in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800155     DOI: 10.1176/appi.ajp.162.4.790

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  12 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

Review 2.  The role of the cerebellum in schizophrenia.

Authors:  Nancy C Andreasen; Ronald Pierson
Journal:  Biol Psychiatry       Date:  2008-04-08       Impact factor: 13.382

Review 3.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

4.  Disrupted modular architecture of cerebellum in schizophrenia: a graph theoretic analysis.

Authors:  Dae-Jin Kim; Jerillyn S Kent; Amanda R Bolbecker; Olaf Sporns; Hu Cheng; Sharlene D Newman; Aina Puce; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2014-04-29       Impact factor: 9.306

5.  Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia.

Authors:  Asli Demirtas-Tatlidede; Catarina Freitas; Jennifer R Cromer; Laura Safar; Dost Ongur; William S Stone; Larry J Seidman; Jeremy D Schmahmann; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2010-12       Impact factor: 4.939

6.  Proton magnetic resonance spectroscopy (H-MRS) in chronic schizophrenia. A single-voxel study in three regions involved in a pathogenetic theory.

Authors:  F Granata; G Pandolfo; S Vinci; C Alafaci; N Settineri; R Morabito; A Pitrone; M Longo
Journal:  Neuroradiol J       Date:  2013-07-16

Review 7.  Developing therapeutics for schizophrenia and other psychotic disorders.

Authors:  Gerard Marek; Kalpana Merchant
Journal:  NeuroRx       Date:  2005-10

Review 8.  T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

Authors:  Bethany K Bracken; Elizabeth D Rouse; Perry F Renshaw; David P Olson
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

9.  Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.

Authors:  Andrea Schmitt; Jiri Koschel; Mathias Zink; Manfred Bauer; Clemens Sommer; Josef Frank; Jens Treutlein; Thomas Schulze; Thomas Schneider-Axmann; Eleni Parlapani; Marcella Rietschel; Peter Falkai; Fritz A Henn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-12       Impact factor: 5.270

10.  Hybrid ICA-Bayesian network approach reveals distinct effective connectivity differences in schizophrenia.

Authors:  D Kim; J Burge; T Lane; G D Pearlson; K A Kiehl; V D Calhoun
Journal:  Neuroimage       Date:  2008-06-17       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.